Logo image of CYCU

CYCURION INC (CYCU) Stock Fundamental Analysis

NASDAQ:CYCU - Nasdaq - US95758L1070 - Common Stock - Currency: USD

0.4256  -0.03 (-5.69%)

Premarket: 0.4175 -0.01 (-1.9%)

Fundamental Rating

0

CYCU gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. CYCU may be in some trouble as it scores bad on both profitability and health. CYCU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYCU has reported negative net income.
CYCU had a negative operating cash flow in the past year.
CYCU Yearly Net Income VS EBIT VS OCF VS FCFCYCU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -500K -1M -1.5M -2M

1.2 Ratios

With a Return On Assets value of -30.03%, CYCU is not doing good in the industry: 90.24% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -30.03%
ROE N/A
ROIC N/A
ROA(3y)-11.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYCU Yearly ROA, ROE, ROICCYCU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CYCU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYCU Yearly Profit, Operating, Gross MarginsCYCU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

CYCU has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, CYCU has a worse debt to assets ratio.
CYCU Yearly Shares OutstandingCYCU Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M
CYCU Yearly Total Debt VS Total AssetsCYCU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

CYCU has an Altman-Z score of -2.52. This is a bad value and indicates that CYCU is not financially healthy and even has some risk of bankruptcy.
CYCU has a worse Altman-Z score (-2.52) than 87.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.52
ROIC/WACCN/A
WACCN/A
CYCU Yearly LT Debt VS Equity VS FCFCYCU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

CYCU has a Current Ratio of 0.04. This is a bad value and indicates that CYCU is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CYCU (0.04) is worse than 95.12% of its industry peers.
CYCU has a Quick Ratio of 0.04. This is a bad value and indicates that CYCU is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CYCU (0.04) is worse than 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
CYCU Yearly Current Assets VS Current LiabilitesCYCU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CYCU have decreased strongly by -77.27% in the last year.
EPS 1Y (TTM)-77.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYCU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYCU Price Earnings VS Forward Price EarningsCYCU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYCU Per share dataCYCU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYCU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYCURION INC

NASDAQ:CYCU (5/7/2025, 8:00:00 PM)

Premarket: 0.4175 -0.01 (-1.9%)

0.4256

-0.03 (-5.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.38M
AnalystsN/A
Price TargetN/A
Short Float %3.8%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -2.52
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.73%
OCF growth 3YN/A
OCF growth 5YN/A